Neoadjuvant Treatment with Paclitaxel and Epirubicin in Invasive??Breast Cancer

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Bernard Fisher, John Bryant, Norman Wolmark et al. · Journal of Clinical Oncology · 1998 · 2.2K citations

Principles and Practice of Radiation Oncology

Carlos Pérez, Luther W. Brady · Journal of Pediatric Hematology/Oncology · 1999 · 1.9K citations

Radiation Medicine, Radiobiology, Radiation Therapy +10

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

Bernard Fisher, A Brown, E.P. Mamounas et al. · Journal of Clinical Oncology · 1997 · 1.8K citations

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

Henry M. Kuerer, Lisa A. Newman, Terry L. Smith et al. · Journal of Clinical Oncology · 1999 · 1.3K citations

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Aman U. Buzdar, Nuhad K. Ibrahim, Deborah Francis et al. · Journal of Clinical Oncology · 2005 · 1.2K citations · Full text